DEF 14A: Vicarious Surgical Proposes Reverse Stock Split to Regain NYSE Compliance, Seeks Stockholder Approval for Incentive Plan Amendment
Proxy Statement
Vicarious Surgical is seeking stockholder approval for a reverse stock split to maintain its NYSE listing and an amendment to its equity incentive plan to attract and retain key personnel.
Summary
- Vicarious Surgical Inc. is holding its 2024 annual meeting of stockholders on June 10, 2024, virtually.
- Stockholders will vote on several proposals, including the election of seven directors, an amendment to the 2021 Equity Incentive Plan, a reverse stock split, and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
- The proposed reverse stock split aims to increase the per-share trading price of the Class A common stock to maintain its listing on the NYSE, with a ratio between 1-for-5 and 1-for-30.
- The amendment to the 2021 Equity Incentive Plan seeks to increase the number of shares available for issuance by 5,000,000.
- The board of directors recommends voting for all proposals.
Sentiment
Score: 6
Explanation: The document is neutral in tone, presenting necessary information for stockholders to make informed decisions. The reverse stock split is a concern, but the company is taking steps to address it.
Positives
- The reverse stock split could broaden the pool of investors and make the stock more attractive to institutional investors.
- Increasing the shares available under the equity incentive plan can help attract, retain, and motivate key personnel.
- Virtual annual meetings enhance stockholder access and participation while reducing costs.
Negatives
- Reverse stock splits can have a negative perception among investors.
- The stock price may not permanently increase after the reverse stock split.
- Delisting from the NYSE could reduce the visibility, liquidity, and value of the Class A common stock.
Risks
- The reverse stock split may not increase the stock price or have the desired effects.
- The market price of the Class A common stock may decrease due to factors unrelated to the reverse stock split.
- The proposed reverse stock split may decrease the liquidity of the Class A common stock.
- The company could be delisted from the NYSE if the reverse stock split is not approved or does not increase the stock price sufficiently.
Future Outlook
The company intends to take steps to increase the value of shares of its Class A common stock through executing its previously-announced business strategy and is considering other options for regaining compliance with the minimum share price requirement, including effecting a reverse stock split, subject to stockholder approval.
Industry Context
Companies facing potential delisting from major exchanges often consider reverse stock splits to artificially inflate their stock price and regain compliance. This is a common strategy, but its success depends on the company's underlying fundamentals and investor sentiment.
Comparison to Industry Standards
- Reverse stock splits are a relatively common tactic employed by companies facing delisting from exchanges like the NYSE and NASDAQ.
- Comparable companies that have recently undertaken reverse stock splits to maintain listing include [Hypothetical Company A] and [Hypothetical Company B].
- The success of these splits in achieving sustained price improvement varies widely, often depending on the company's ability to demonstrate improved financial performance and growth prospects following the split.
Related Party Transactions
- The company entered into an Amended and Restated Registration Rights Agreement with the Sponsor, D8's independent directors, and certain Legacy Vicarious stockholders.
- The company entered into a Director Nomination Agreement with the Sponsor.
Stakeholder Impact
- Shareholders will be impacted by the reverse stock split and the potential for dilution from the equity incentive plan amendment.
- Employees may be impacted by the equity incentive plan amendment, which could affect their compensation.
- The company's ability to maintain its NYSE listing could impact its relationships with customers, suppliers, and creditors.
Next Steps
- Stockholders will vote on the proposals at the annual meeting on June 10, 2024.
- The board will determine whether to proceed with the reverse stock split and set the specific ratio if approved.
- The company will continue to execute its business strategy to increase the value of its Class A common stock.
Key Dates
| Date | Description |
|---|---|
| April 15, 2021 | Date of the Agreement and Plan of Merger among D8 Holdings Corp., Snowball Merger Sub, Inc., Vicarious Surgical Inc., and Adam Sachs. |
| September 17, 2021 | Closing date of the Business Combination. |
| September 20, 2023 | Date the company received notice from the NYSE regarding minimum share price non-compliance. |
| February 20, 2024 | Date the Board approved the reverse stock split, subject to stockholder approval. |
| April 1, 2024 | Date for beneficial ownership of common stock information. |
| April 12, 2024 | Date the board nominated directors and approved the equity incentive plan amendment. |
| April 19, 2024 | Record date for determining stockholders eligible to vote at the annual meeting. |
| April 23, 2024 | Intended date to begin sending the Notice of Internet Availability of Proxy Materials to stockholders. |
| June 9, 2024 | Deadline for telephone and Internet voting for stockholders of record. |
| June 10, 2024 | Date of the 2024 annual meeting of stockholders. |
| December 24, 2024 | Deadline to receive stockholder proposals for inclusion in the 2025 proxy statement. |
| February 10, 2025 | Earliest date to receive stockholder proposals for presentation at the 2025 annual meeting. |
| March 12, 2025 | Latest date to receive stockholder proposals for presentation at the 2025 annual meeting. |
Keywords
Reverse Stock Split, Equity Incentive Plan, Annual Meeting, Proxy Statement, Stockholders, NYSE, Delisting, Directors, Shares, Voting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.